FindTrial
Sign In

prospective study on allogeneic hematopoietic stem cell transplant for the treatment of leukemia with 11q23/MLL

allogeneic hematopoietic stem cell transplant for the treatment of leukemia with 11q23/MLL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002739
Enrollment
Unknown
Registered
2012-11-29
Start date
2007-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia with 11q23/MLL

Interventions

Case series:allo-HSCT

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 60 Years

Inclusion criteria

Inclusion criteria: leukemia with 11q23/MLL undergoing allo-HSCT

Exclusion criteria

Exclusion criteria: 1. contraindication for HSCT; 2. pregnancy; 3. mental illness.

Design outcomes

Primary

MeasureTime frame
Relapse rate;—

Contacts

Public ContactXiaojun Huang
huangxiaojun@bjmu.edu.cn+86 10 88326006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026